Indeed, in the study by Katanasaka et al., the authors demonstrated that GRP78-targeted WIFPWIQL-modified liposomes containing doxorubicin, efficiently bound to colon carcinoma cells and HUVEC endothelial cells [117]. The gene discussed is HSPA5; the disease is colon carcinoma.